Literature DB >> 8771443

Profile characteristics of the MPI-DLV clusters of pain patients.

R Lousberg1, N Groenman, A Schmidt.   

Abstract

This article describes an investigation into whether there are differences among the four pain patient clusters from the Multidimensional Pain Inventory-Dutch Language Version (MPI-DLV) in terms of prescribed analgesic medication, level of intelligence, and other personality characteristics (MMPI). Dysfunctional patients were distinguished by a higher level of analgesic medication intake. Patients classified as Average were marked by a marginally significant higher level of intelligence. The personality profile of Interpersonally Distressed patients indicated an elevated neurotic triad and a tendency to a passive-aggressive personality structure. Patients classified as Dysfunctional and Average were marked by the so-called conversion-V. There were no elevated scales in the Adaptive Coper profile. Clinical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771443     DOI: 10.1002/(SICI)1097-4679(199603)52:2<161::AID-JCLP6>3.0.CO;2-X

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  3 in total

1.  The clinical utility of the Multidimensional Pain Inventory (MPI) in characterizing chronic disabling occupational musculoskeletal disorders.

Authors:  YunHee Choi; Tom G Mayer; Mark Williams; Robert J Gatchel
Journal:  J Occup Rehabil       Date:  2013-06

2.  Multi-modal examination of psychological and interpersonal distinctions among MPI coping clusters: a preliminary study.

Authors:  Doerte U Junghaenel; Francis J Keefe; Joan E Broderick
Journal:  J Pain       Date:  2009-09-26       Impact factor: 5.820

3.  French translation of the Multidimensional Pain Inventory: L'inventaire multidimensionnel de la douleur.

Authors:  Simon Laliberté; Julie Lamoureux; Michael J L Sullivan; Jean-Marc Miller; Julie Charron; Donald Bouthillier
Journal:  Pain Res Manag       Date:  2008 Nov-Dec       Impact factor: 3.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.